Phase II prostate cancer vaccine trial: Report of a study involving 37 patients with disease recurrence following primary treatment

BACKGROUND A phase II trial was conducted to assess the efficacy of infusions of dendritic cells (DC) and two HLA‐A2‐specific prostate‐specific membrane antigen (PSMA) peptides (PSM‐P1 and ‐P2). This report describes the evaluation of 37 subjects admitted with presumed local recurrence of prostate c...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Prostate 1999-04, Vol.39 (1), p.54-59
Hauptverfasser:	Murphy, G.P., Tjoa, B.A., Simmons, S.J., Ragde, H., Rogers, M., Elgamal, A., Kenny, G.M., Troychak, M.J., Salgaller, M.L., Boynton, A.L.
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Aged, 80 and over Biological and medical sciences cancer vaccine cancer vaccine, local recurrence Cancer Vaccines clinical trial dendritic cells Humans immunotherapy local recurrence Male Medical sciences Middle Aged Neoplasm Recurrence, Local Nephrology. Urinary tract diseases prostate cancer prostate- specific membrane antigen Prostatic Neoplasms - prevention & control Tumors of the urinary system Urinary tract. Prostate gland
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!